F Fuzkk Atlas of India
#68FUZKK atlas leaders 1–100

Orchid Pharma Ltd

Tamil Nadu · Tamil Nadu / Chennai

Antibiotics and fermentation

Manufacturing profile

Antibiotics and fermentation

State / territory: Tamil Nadu

Pharmaceutical cluster: Tamil Nadu / Chennai

Selection basis

The company is placed in positions 1–100 as a major Indian manufacturer, exporter, API/CDMO, generics, vaccine or biopharma participant.

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Licence status, GMP status and the actual site portfolio must be rechecked through CDSCO and the relevant State Drug Controller.

Representative manufacturing and QC chain

  1. 1Seed preparation and industrial fermentation
  2. 2Broth clarification and primary recovery
  3. 3Extraction, crystallisation and purification
  4. 4Sterile or non-sterile formulation
  5. 5Potency, impurity profile, bioburden and residual solvents

Relevant FUZKK packages

India: national essential medicines QC packageFermentation & Antibiotic Intermediates QC SuiteGlobal API & Biosimilars QC Suite

Product/API utilities

Antibiotic Intermediate Release CheckerAntibiotic Potency Assay CheckerFermentation Impurity Profile AnalyzerFermentation Residual Solvent CheckerFermentation Bioburden Trend CheckerFermentation Yield Consistency CheckerSix APAImpurity Profile CheckerSeven ACAImpurity Profile Checker

Lumex — instrumental QC

System Suitability Parameters Checker

LabEx — laboratory QC

Assay & Impurity HPLC Quality Checker

Medical Devices — equipment and software lifecycle

Supplier Evaluation CheckerCalibration Status CheckerProcess Validation CheckerChange Control Impact CheckerRequirement Traceability CheckerData Integrity Security Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Licence status, GMP status and the actual site portfolio must be rechecked through CDSCO and the relevant State Drug Controller.

Methodology